Serge DepatieLAR Research Inc.LRI.TOTOP PICKMay 07, 2008

Located in Montreal which is a hub for clinical trials in this company has taken the opportunity there. Has grown tremendously and he sees no end in sight in terms of obtaining contracts by the pharmaceutical industry, which more and more has to outsource research work. They have quality contracts.

Serge Depatie

Owned

Unlock Rating

$7.74

Stock price when the opinion was issued

biotechnologypharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Most Recent Experts

Kevin Simpson

Capital Wealth Planning

Karen Firestone, CEO, Aureus Asset Management

Aureus Asset Management

Bryn Talkington

Requisite Capital Management

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Brianne Gardner

Raymond James

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Serge DepatieLAR Research Inc.LRI.TOTOP PICKMay 07, 2008

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals